Abnormal liver enzymes 2-3 months after liver transplantation in a patient with hepatitis C: Report of a case
β Scribed by Kymberly D.S. Watt
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 232 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20943
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 44-year-old white man was diagnosed with chronic hepatitis B in 1999 by his primary-care physician. His laboratory results were as follows: aspartate aminotransferase (AST) 144 IU/L, alanine aminotransferase (ALT) 82 IU/L, hepatitis B surface antigen (HBsAg) positive, hepatitis B e antigen (HBeAg)
Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct clinical entities that may complicate liver disease. Although HPS and PPHTN are different, several reports describe 6 patients in whom both conditions have occurred, either concurrently or sequentially, sometimes wit
Some chromosomal alterations can be associated with vascular abnormalities. For instance, Turner syndrome can be complicated by agenesis or hypoplasia of the portal venous system causing presinusoidal portal hypertension. Liver transplantation to treat this condition overcomes portal hypertension an
Serum alanine transaminase (ALT) levels are used to select hepatitis C virus (HCV)-infected patients for treatment and liver biopsy. However, the natural history of these measurements is poorly understood. To examine the hypothesis that ALT levels vary over time in HCV-infected patients, serial seru